Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.

Saved in:
Bibliographic Details
Title: Randomized phase II study of the neurokinin 1 receptor antagonist CJ-11,974 in the control of cisplatin-induced emesis.
Authors: Hesketh PJ; Section of Medical Oncology, St. Elizabeth's Medical Center, Boston, MA 02135, USA. phesketh@aol.com, Gralla RJ, Webb RT, Ueno W, DelPrete S, Bachinsky ME, Dirlam NL, Stack CB, Silberman SL
Source: Journal of clinical oncology : official journal of the American Society of Clinical Oncology [J Clin Oncol] 1999 Jan; Vol. 17 (1), pp. 338-43.
Publication Type: Clinical Trial; Clinical Trial, Phase II; Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
Journal Info: Publisher: American Society of Clinical Oncology Country of Publication: United States NLM ID: 8309333 Publication Model: Print Cited Medium: Print ISSN: 0732-183X (Print) Linking ISSN: 0732183X NLM ISO Abbreviation: J Clin Oncol Subsets: MEDLINE
Database: MEDLINE Ultimate
Description
ISSN:0732-183X
DOI:10.1200/JCO.1999.17.1.338